• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[检验医学中的决策分析模型——尿痛女性微生物学检查的合理应用]

[A decision analysis model in laboratory medicine--appropriate usage of microbiological examination in women with dysuria].

作者信息

Inoue Y

机构信息

Department of Medical Informatics, Yamaguchi University School of Medicine, Ube.

出版信息

Rinsho Byori. 1990 May;38(5):587-92.

PMID:2199709
Abstract

Decision analysis is a noteworthy methods to solve complex medical problems and select best alternative under uncertainty, and its practical applications in laboratory medicine are anticipated for appropriate usage of laboratory resources. From the view of classical microbiology, it is necessary to identify bacteria causing an infection and select sensitive antibiotics to this pathogen. Decision analysis was used to estimate the clinical and economic implications of microbiological testing for urinary tract infections at the initial visit for all women with acute dysuria. A strategy of initial culture was compared with a strategy involving the use of culture only for patients with symptoms persisting 3 days after initial therapy (wait 3 days strategy). Expected direct cost and medical care days were 10,748 yen and 7.12 days for initial culture strategy and 6872 yen and 7.24 days for wait 3 days strategy. Sensitivity analysis showed that initial culture strategy was not cost effective when the frequency of antibiotics resistant organisms would be increased or required days to obtain microbiological tests results would be decreased.

摘要

决策分析是解决复杂医学问题并在不确定性情况下选择最佳方案的一种值得关注的方法,预计其在检验医学中的实际应用将有助于实验室资源的合理利用。从经典微生物学的角度来看,有必要鉴定引起感染的细菌并选择对该病原体敏感的抗生素。决策分析被用于评估对所有急性排尿困难女性初诊时进行尿路感染微生物检测的临床和经济影响。将初始培养策略与仅对初始治疗后症状持续3天的患者使用培养的策略(等待3天策略)进行了比较。初始培养策略的预期直接成本和医疗天数分别为10,748日元和7.12天,等待3天策略为6872日元和7.24天。敏感性分析表明,当抗生素耐药菌的频率增加或获得微生物检测结果所需天数减少时,初始培养策略不具有成本效益。

相似文献

1
[A decision analysis model in laboratory medicine--appropriate usage of microbiological examination in women with dysuria].[检验医学中的决策分析模型——尿痛女性微生物学检查的合理应用]
Rinsho Byori. 1990 May;38(5):587-92.
2
[A decision analysis model for appropriate laboratory use--should test of urine gram stain be done for selecting antibiotics at the initial visit on women with acute dysuria].
Rinsho Byori. 1991 Jul;39(7):773-80.
3
Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies.门诊女性疑似尿路感染的评估:基于办公室策略的成本效用分析
J Fam Pract. 1997 Jan;44(1):49-60.
4
Clinical symptoms predictive of recurrent urinary tract infections.预测复发性尿路感染的临床症状。
Am J Obstet Gynecol. 2007 Jul;197(1):74.e1-4. doi: 10.1016/j.ajog.2007.02.044.
5
Evaluation of dysuria in adults.成人排尿困难的评估。
Am Fam Physician. 2002 Apr 15;65(8):1589-96.
6
Management of urinary tract infection in general practice: a cost-effectiveness analysis.全科医疗中尿路感染的管理:一项成本效益分析。
Br J Gen Pract. 2000 Aug;50(457):635-9.
7
Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?幽门螺杆菌感染的诊断和治疗成本:基于药敏试验选择治疗方案何时具有成本效益?
Am J Gastroenterol. 1999 Mar;94(3):725-9. doi: 10.1111/j.1572-0241.1999.00943.x.
8
Evaluation of clinical algorithms for the diagnosis of gonococcal and chlamydial infections among men with urethral discharge or dysuria and women with vaginal discharge in Benin.对贝宁尿道分泌物或排尿困难男性及阴道分泌物女性淋病奈瑟菌和沙眼衣原体感染诊断临床算法的评估。
Sex Transm Infect. 1998 Jun;74 Suppl 1:S44-9.
9
Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care.基层医疗中急性单纯性尿路感染实验室报告的抗生素耐药性的临床相关性。
J Antimicrob Chemother. 2006 Nov;58(5):1000-8. doi: 10.1093/jac/dkl368. Epub 2006 Sep 23.
10
[Usefulness of microbiological test in clinical decision making--from the view point of clinician].[微生物学检测在临床决策中的作用——从临床医生的视角来看]
Rinsho Byori. 1993 May;41(5):557-61.